摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氯-6-甲基烟腈 | 1256835-28-5

中文名称
5-氯-6-甲基烟腈
中文别名
——
英文名称
5-chloro-6-methylpyridine-3-carbonitrile
英文别名
5-chloro-6-methylnicotinonitrile
5-氯-6-甲基烟腈化学式
CAS
1256835-28-5
化学式
C7H5ClN2
mdl
——
分子量
152.583
InChiKey
ZTBGMWQLXAALOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    36.7
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    5-氯-6-甲基烟腈N-溴代丁二酰亚胺(NBS)偶氮二异丁腈 作用下, 以 四氯化碳 为溶剂, 反应 14.0h, 以120 mg的产率得到6-(bromomethyl)-5-chloropyridine-3-carbonitrile
    参考文献:
    名称:
    [EN] ΡΡΑRγ MODULATORS AND METHODS OF USE
    [FR] MODULATEURS DE ΡΡΑRγ ET MÉTHODES D'UTILISATION
    摘要:
    本文公开了一种新型的PPARy调节剂,其化学式为(I),以及其药学上可接受的盐,包含它们的制药组合物,以及使用它们的方法,特别是用于治疗癌症的方法。
    公开号:
    WO2022099144A1
  • 作为产物:
    描述:
    iodopyridineN-叔丁氧羰基-4-哌啶酮lithium chloro-isopropyl-magnesium chloride甲醇溶剂黄146 作用下, 以 四氢呋喃 为溶剂, 以57%的产率得到tert-butyl 3-chloro-2-methyl-5-oxo-5H-spiro[furo[3,4-b]pyridine-7,4'-piperidine]-1'-carboxylate
    参考文献:
    名称:
    A concise synthesis of 3,4-fused spiro[isobenzofuran-3-ones], spiro[furo[3,4- b ]pyridin-5(7 H )-ones], 3-aryl-, and alkylphthalides
    摘要:
    A synthetically useful protocol has been developed for the preparation of highly functionalized 3,4-fused spiro[isobenzofuran-3-ones], spiro[furo[3,4-b]pyridin-5(7H)-ones], 3-aryl-, and alkylphthalides. Reaction of 2-iodobenzoate esters and 2-iodopyridine carboxylate esters with i-PrMgCl center dot LiCl in the presence of cyclic ketones under standard Barbier reaction conditions affords 3,4-fused spiro[isobenzofuran-3-ones] and spiro[furo[3,4-b]pyridin-5(7H)-ones] in good to excellent yields. Step-wise addition of i-PrMgCl center dot LiCl to 2-iodobenzoate esters followed by trapping with various aldehydes yields 3-aryl and 3-alkylphthalides; whereas, under similar conditions access to 3-aryl and 3-alylazaphthalides is also possible. Extension of this methodology toward the preparation of 3-n-butylphthalide and chrycolide, a natural product isolated from the leaves and stems of Chrysanthemum coronarium, is also described. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2013.02.051
点击查看最新优质反应信息

文献信息

  • [EN] BICYCLIC THIAZINE AND OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE<br/>[FR] DÉRIVÉS DE THIAZINE ET D'OXAZINE BICYCLIQUES EN TANT QU'INHIBITEURS DE BÊTA-SÉCRÉTASE ET PROCÉDÉS D'UTILISATION
    申请人:AMGEN INC
    公开号:WO2018112084A1
    公开(公告)日:2018-06-21
    The present disclosure provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula (I): (Formula (I)) wherein variables X, Y, R2, R3, R4, R5, R6, and n of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, and uses of the compounds and compositions for treatment of disorders and/or conditions related to Aβ plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer 's disease, cognitive deficits, cognitive impairments, and other central nervous system conditions.
    本公开提供了一类新的化合物,用于调节β-分泌酶(BACE)活性。这些化合物具有一般式(I):(式(I)),其中式(I)中的变量X、Y、R2、R3、R4、R5、R6和n在此处定义。本公开还提供了包括这些化合物的药物组合物,以及这些化合物和组合物用于治疗与Aβ斑块形成和沉积相关的疾病和/或症状的用途,这些疾病和症状是由BACE的生物活性引起的。这种由BACE介导的疾病包括阿尔茨海默病、认知缺陷、认知障碍和其他中枢神经系统疾病。
  • PYRIDAZINONE COMPOUND OR ITS SALT, AND HERBICIDE CONTAINING IT
    申请人:ISHIHARA SANGYO KAISHA, LTD.
    公开号:US20200172517A1
    公开(公告)日:2020-06-04
    A novel herbicide having remarkable herbicidal activities against undesired plants is provided. A pyridazinone compound represented by the formula (I) or its salt: wherein X is —O—, —S—, —SO—, —SO 2 — or —N(Y)—; Q is monocyclic aryl which may be substituted by Z, monocyclic heteroaryl which may be substituted by Z or the like; Y is a hydrogen atom or alkyl; Z is halogen, alkyl or the like; R 1 is alkyl, alkenyl or the like; R 2 is a hydrogen atom, alkyl or the like; R 3 is halogen, hydroxy or the like; R 4 is a hydrogen atom, alkyl or the like; and n is an integer of from 0 to 4.
    提供了一种对不受欢迎的植物具有显著除草活性的新型除草剂。一种由以下式(I)或其盐表示的吡啶并酮化合物: 其中X为—O—,—S—,—SO—,—SO2—或—N(Y)—;Q为可以由Z取代的单环芳基,可以由Z取代的单环杂芳基或类似物;Y为氢原子或烷基;Z为卤素,烷基或类似物;R1为烷基,烯烃基或类似物;R2为氢原子,烷基或类似物;R3为卤素,羟基或类似物;R4为氢原子,烷基或类似物;n为0到4的整数。
  • OXAZINE DERIVATIVES AND A PHARMACEUTICAL COMPOSITION FOR INHIBITING BACE1 CONTAINING THEM
    申请人:Masui Moriyasu
    公开号:US20140051691A1
    公开(公告)日:2014-02-20
    The present invention provides a compound of formula (I): wherein —X═ is —CR 7 ═ or —N═, ring B is a substituted or unsubstituted carbocycle or a substituted or unsubstituted heterocycle, R 1 is substituted or unsubstituted alkyl or the like, R 2 a and R 2 b are each independently hydrogen, substituted or unsubstituted alkyl or the like, R 3 and R 4 are each independently hydrogen, halogen, substituted or unsubstituted alkyl or the like, R 5 is hydrogen, substituted or unsubstituted alkyl or the like, each R 6 is independently halogen, hydroxy, substituted or unsubstituted alkyl or the like, R 7 is hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl or the like, p is an integer of 0 to 3, or a pharmaceutically acceptable salt thereof which has an effect of inhibiting amyloid β production, especially an effect of inhibiting BACE1, and which is useful as a therapeutic or prophylactic agent for diseases induced by production, secretion and/or deposition of amyloid β proteins.
    本发明提供了一种化合物的公式(I):其中—X═是—CR7═或—N═,环B是取代或未取代的碳环或取代或未取代的杂环,R1是取代或未取代的烷基或类似物,R2和R2'分别独立地是氢、取代或未取代的烷基或类似物,R3和R4分别独立地是氢、卤素、取代或未取代的烷基或类似物,R5是氢、取代或未取代的烷基或类似物,每个R6独立地是卤素、羟基、取代或未取代的烷基或类似物,R7是氢、卤素、羟基、取代或未取代的烷基或类似物,p是0到3的整数,或其在药学上可接受的盐,具有抑制淀粉样蛋白β产生的作用,特别是抑制BACE1的作用,并且可用作由淀粉样蛋白β蛋白的产生、分泌和/或沉积引起的疾病的治疗或预防剂。
  • PYRAZOLE AMIDE COMPOUNDS AND USES THEREOF
    申请人:Liu Changling
    公开号:US20130225585A1
    公开(公告)日:2013-08-29
    Disclosed is a pyrazole amide compound having fungicidal activity, with a structure shown by the general formula (I): Each of the substituents of the compound being defined as in the description. The compound of the present invention has fungicidal activity, and excellent prevention and controlling effects on diseases, such as cucumber downy mildew, corn rust, wheat powdery mildew, rice blast, etc., and in particular, a better prevention and controlling effect on cucumber downy mildew and corn rust. Also disclosed is a process for preparing the compound, a fungicidal composition containing the compound of general formula (I) and the use thereof in preventing and controlling disease in crops.
    本发明揭示了一种具有杀真菌活性的吡唑酰胺化合物,其结构由通式(I)所示:化合物的每个取代基均如描述中所定义。本发明的化合物具有杀真菌活性,并对瓜类霜霉病、玉米锈病、小麦白粉病、稻稻瘟等疾病具有优异的预防和控制效果,尤其对瓜类霜霉病和玉米锈病有更好的预防和控制效果。还公开了一种制备该化合物的方法,含有通式(I)化合物的杀真菌组合物以及其在农作物疾病预防和控制中的应用。
  • [EN] 3.ALPHA.-HYDROXY, 17.BETA.-C(O)-N-ARYL SUBSTITUTED NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF<br/>[FR] STÉROÏDES NEUROACTIFS 3.ALPHA.-HYDROXY, 17.BETA.-C(O)-N-ARYL-SUBSTITUÉS ET COMPOSITIONS ASSOCIÉES
    申请人:SAGE THERAPEUTICS INC
    公开号:WO2021262836A1
    公开(公告)日:2021-12-30
    Provided herein is a compound of the Formula (I) or a pharmaceutically acceptable salt thereof, wherein R2a, R2b, R3a, R4a, R4b, R5, R6, R7, R11a, R11b, R15a, R15b, R16,R17, R19, RX, RY, and t are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds, e.g., in the treatment of CNS-related disorders.
    本文提供了一种公式(I)的化合物或其药学上可接受的盐,其中R2a,R2b,R3a,R4a,R4b,R5,R6,R7,R11a,R11b,R15a,R15b,R16,R17,R19,RX,RY和t在此定义。本文还提供了含有公式(I)的化合物的药物组合物和使用该化合物的方法,例如用于治疗中枢神经系统相关疾病。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-